Quantcast
Last updated on April 17, 2014 at 17:30 EDT

Latest Sequenom Stories

2012-11-21 08:23:15

SAN DIEGO, Nov. 21, 2012 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced that the American College of Obstetricians and Gynecologists (ACOG) Committee on Genetics and the Society for Maternal-Fetal Medicine (SMFM) Publications Committee issued a joint Committee Opinion on November 20, 2012, recommending that cell-free fetal DNA testing be offered to patients at increased risk of...

2012-11-12 16:25:47

SAN DIEGO, Nov. 12, 2012 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced its wholly-owned subsidiary, Sequenom Center for Molecular Medicine (Sequenom CMM), presented results from a study of its RetnaGene AMD laboratory-developed test to predict risk of disease progression during the 2012 Joint Meeting of the American Academy of Ophthalmology and the Asia-Pacific Academy of...

2012-11-08 16:28:22

SAN DIEGO, Nov. 8, 2012 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today reported revenue of $22.9 million for the third quarter of 2012, an increase of 25% from revenue of $18.3 million in the second quarter of 2012 and a 68% increase compared to revenue of $13.6 million for the third quarter of 2011. Revenues from the Sequenom Center for Molecular Medicine (Sequenom CMM) diagnostic testing services operating...

2012-11-06 16:27:45

SAN DIEGO, Nov. 6, 2012 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced the Company's participation at the upcoming Lazard Capital Markets 9(th) Annual Healthcare Conference in New York and the Jefferies 2012 Global Healthcare Conference in London. On Tuesday, November 13, Harry F. Hixson Jr., Ph.D., Sequenom's Chief Executive Officer, will present at the Lazard Capital Markets...

2012-10-25 11:26:06

REDWOOD CITY, Calif., Oct. 25, 2012 /PRNewswire/ --Verinata Health, Inc., a privately-held company dedicated to maternal and fetal health, today announced that it has commenced an action against Ariosa Diagnostics, Inc. (Ariosa) and Laboratory Corporation of America Holdings (LabCorp) in federal court in the Northern District of California. The action asserts that Ariosa and LabCorp infringe U. S. Patent No. 8,296,076 (the '076 patent) entitled "Noninvasive Diagnosis of Fetal...

2012-10-18 15:23:23

SAN DIEGO, Oct. 18, 2012 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced that the California Technology Assessment Forum completed an independent evaluation of the cell-free fetal DNA technology used in the Sequenom Center for Molecular Medicine's (Sequenom CMM) MaterniT21 PLUS(TM) laboratory-developed test (LDT). CTAF recommended that the use of cell-free fetal DNA as a...

2012-10-15 07:28:31

SAN DIEGO, Oct. 15, 2012 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, today announced it will report financial results for the third quarter of 2012 after closing of the NASDAQ Global Market on Thursday, November 8, 2012. A conference call hosted by Harry F. Hixson, Jr., Ph.D., Chairman and CEO, and other members of senior management will take place on the same day at 5:00 pm ET (2:00...

2012-10-11 07:27:23

SAN DIEGO, Oct. 11, 2012 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced the appointment of Bill Bowen as Senior Vice President and General Counsel. Mr. Bowen will report to Dr. Harry F. Hixson, Chairman and CEO and will be responsible for all company legal and patent activities. "With Mr. Bowen's extensive expertise in biotechnology and medical device corporate counsel, he brings the critical skills to...

2012-09-17 10:23:55

SAN DIEGO, Sept. 17, 2012 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM) today announced the completion of its offering of $130.0 million aggregate principal amount of 5.00% Convertible Senior Notes due 2017 (the "Convertible Notes") in a private offering, including $20.0 million aggregate principal amount of notes sold pursuant to the full exercise of an over-allotment option previously granted to the initial purchasers. Sequenom intends to use the net proceeds from this offering to fund...

2012-09-13 02:26:54

MONROVIA, Calif., Sept. 13, 2012 /PRNewswire/ -- STAAR Surgical Company (Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that its Board of Directors has elected Charles Slacik, CPA, 58, to the Board. Mr. Slacik has over 30 years of executive level experience in the health care industry, serving most recently as the Senior Vice President and Chief Financial Officer of Beckman Coulter Inc. His appointment brings the number...